Selected Publications

Academic Article

Year Title Altmetric
2019 Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial among Preschool-Aged Children in Urban BangladeshClinical Infectious Diseases.  69:777-785. 2019
2019 The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi ChildrenClinical Infectious Diseases.  69:786-794. 2019
2019 Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasonsEurosurveillance.  24. 2019
2019 Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccinesInfluenza and Other Respiratory Viruses2019
2018 Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses after Influenza Vaccination in AdultsJournal of Infectious Diseases.  218:1571-1581. 2018
2018 Human infection with avian influenza A(H7N2) virus—Virginia, 2002Influenza and Other Respiratory Viruses.  12:529-532. 2018
2018 Kinetics of Serological Responses in Critically Ill Patients Hospitalized with 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011Journal of Infectious Diseases.  217:1078-1088. 2018
2017 Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, BangladeshInfluenza and Other Respiratory Viruses.  11:394-398. 2017
2017 Phenotype and function of myeloidderived suppressor cells induced by Porphyromonas gingivalis infectionInfection and Immunity.  85. 2017
2017 Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applicationsInfluenza and Other Respiratory Viruses.  11:289-297. 2017
2017 A pyrosequencing-based approach to high-throughput identification of influenza A(H3N2) virus clades harboring antigenic drift variantsJournal of Clinical Microbiology.  55:145-154. 2017
2017 CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statementInfluenza and Other Respiratory Viruses.  11:2-14. 2017
2017 Cross-reactive antibody responses to novel h5nx influenza viruses following homologous and heterologous prime-boost vaccination with a prepandemic stockpiled a(h5n1) vaccine in humansJournal of Infectious Diseases.  216:S555-S559. 2017
2017 Effect of priming with seasonal influenza a(h3n2) virus on the prevalence of cross-reactive hemagglutination-inhibition antibodies to swine-origin a(h3n2) variantsJournal of Infectious Diseases.  216:S539-S547. 2017
2017 Mild respiratory illness among young children caused by highly pathogenic avian influenza a (h5n1) virus infection in Dhaka, Bangladesh, 2011Journal of Infectious Diseases.  216:S520-S528. 2017
2016 Seasonal influenza vaccination of children induces humoral and cell-mediated immunity beyond the current season: Cross-reactivity with past and future strainsJournal of Infectious Diseases.  214:1477-1486. 2016
2016 Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, ThailandClinical Infectious Diseases.  62:383-391. 2016
2015 IL-1R/TLR2 through MyD88 divergently modulates osteoclastogenesis through regulation of nuclear factor of activated T cells c1 (NFATc1) and B lymphocyte-induced maturation protein-1 (Blimp1)Journal of Biological Chemistry.  290:30163-30174. 2015
2015 Live animal markets in Minnesota: A potential source for emergence of novel influenza a viruses and interspecies transmissionClinical Infectious Diseases.  61:1355-1362. 2015
2015 International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISEClinical and Diagnostic Laboratory Immunology.  22:957-964. 2015
2015 NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infectionEuropean Journal of Immunology.  45:758-772. 2015
2015 A newly emerged swine-origin influenza a(H3N2) variant dampens host antiviral immunity but induces potent inflammasome activationJournal of Infectious Diseases.  212:1923-1929. 2015
2015 Antibody to influenza virus neuraminidase: An independent correlate of protectionJournal of Infectious Diseases.  212:1191-1199. 2015
2015 Highly pathogenic avian influenza a(H5n1) virus infection among workers at live bird markets, Bangladesh, 2009–2010Emerging Infectious Diseases.  21:629-637. 2015
2014 Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutininsInfluenza and Other Respiratory Viruses.  8:628-635. 2014
2014 Assessing the impact of public health interventions on the transmission of pandemic H1N1 influenza a virus aboard a Peruvian navy shipInfluenza and Other Respiratory Viruses.  8:353-359. 2014
2014 Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residentsInfluenza and Other Respiratory Viruses.  8:516-523. 2014
2014 IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United StatesClinical and Diagnostic Laboratory Immunology.  21:1054-1060. 2014
2014 Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α-actinin-4 for viral replicationEuropean Journal of Biochemistry.  281:2899-2914. 2014
2014 Molecular determinants of influenza virus pathogenesis in miceCurrent Topics in Microbiology and Immunology.  385:243-274. 2014
2014 Serologic evidence of influenza A(H1N1) pdm09 virus infection in northern sea ottersEmerging Infectious Diseases.  20:915-917. 2014
2014 Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humansJournal of Infectious Diseases.  209:986-994. 2014
2013 Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians-southwestern United States, May 1-July 21, 2009Influenza and Other Respiratory Viruses.  7:1361-1369. 2013
2013 Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): Role of the host immune response in pathogenesisAmerican Journal of Pathology.  183:1258-1268. 2013
2013 Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010Influenza and Other Respiratory Viruses.  7:52-53. 2013
2013 Considerations regarding appropriate sample size for conducting ferret transmission experimentsFuture Microbiology.  8:961-965. 2013
2013 Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012Clinical Infectious Diseases.  57. 2013
2013 Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in miceJournal of Infectious Diseases.  207:1576-1584. 2013
2013 Alexander (Sasha) I. Klimov, PhD, ScD (1943-2013)Influenza and Other Respiratory Viruses.  7:356-357. 2013
2013 Immunological assessment of influenza vaccines and immune correlates of protectionExpert Review of Vaccines.  12:519-536. 2013
2013 Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in miceJournal of Infectious Diseases.  207:501-510. 2013
2013 Estimating age-specific cumulative incidence for the 2009 influenza pandemic: A meta-analysis of A(H1N1)pdm09 serological studies from 19 countriesInfluenza and Other Respiratory Viruses.  7:872-886. 2013
2013 Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to porphyromonas gingivalisJournal of Leukocyte Biology.  93:21-31. 2013
2013 Seropositivity for influenza A(H1N1) pdm09 virus among frontline health care personnelEmerging Infectious Diseases.  19:140-143. 2013
2012 Protecting adults from influenza: Tis the season to learn from the pandemicJournal of Infectious Diseases.  206:803-805. 2012
2012 Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infectionJournal of Immunology.  189:2257-2265. 2012
2012 Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003Emerging Infectious Diseases.  18:1128-1131. 2012
2012 Avian influenza A (H5N1) virus antibodies in poultry cullers, South Korea, 2003-2004Emerging Infectious Diseases.  18:986-988. 2012
2012 The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: A serologic investigation demonstrating early transmissionInfluenza and Other Respiratory Viruses.  6. 2012
2012 Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular routeAntimicrobial Agents and Chemotherapy.  56:1616-1618. 2012
2012 Local innate immune responses and influenza virus transmission and virulence in ferretsJournal of Infectious Diseases.  205:474-485. 2012
2012 Use of a human influenza challenge model to assess person-to-person transmission: Proof-of-concept studyJournal of Infectious Diseases.  205:35-43. 2012
2011 Transmission of 2009 pandemic influenza a (H1N1) virus among healthcare personnel-Southern California, 2009Infection Control and Hospital Epidemiology.  32:1149-1157. 2011
2011 A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008Journal of Infectious Diseases.  204:1165-1171. 2011
2011 Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activationInfection and Immunity.  79:3792-3800. 2011
2011 Serologically confirmed household transmission of 2009 pandemic influenza a (H1N1) virus during the first pandemic wave - New York City, april-may 2009Clinical Infectious Diseases.  53:455-462. 2011
2011 The ferret as a model organism to study influenza A virus infectionDisease Models & Mechanisms.  4:575-579. 2011
2011 TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-κBJournal of Biological Chemistry.  286:24159-24169. 2011
2011 Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A virusesJournal of Immunological Methods.  369:115-124. 2011
2011 Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populationsJournal of Clinical Microbiology.  49:2210-2215. 2011
2011 Serologic assays for influenza surveillance, diagnosis and vaccine evaluationExpert Review of Anti-infective Therapy.  9:669-683. 2011
2011 TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin BJournal of Immunology.  186:5772-5783. 2011
2011 Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infectionJournal of Infectious Diseases.  203:40-48. 2011
2010 Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virusJournal of Infectious Diseases.  202:1161-1170. 2010
2010 Influenza A virus transmission: Contributing factors and clinical implicationsExpert Reviews in Molecular Medicine.  12. 2010
2009 A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vetnam/1203/2004, in MiceJournal of Infectious Diseases.  200:1874-1883. 2009
2009 Systems-based candidate genes for human response to influenza infectionInfection, Genetics and Evolution.  9:1148-1157. 2009
2009 Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine productionInfluenza and Other Respiratory Viruses.  3:287-295. 2009
2009 Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004Archives of Virology.  154:1249-1261. 2009
2009 Risk factors associated with subclinical human infection with avian influenza a (H5N1) virus-cambodia, 2006Journal of Infectious Diseases.  199:1744-1752. 2009
2009 Past, present, and possible future human infection with influenza virus A subtype H7Emerging Infectious Diseases.  15:859-865. 2009
2009 Reply to ZhangJournal of Infectious Diseases.  199:1250-1251. 2009
2009 Reproducibility of serologic assays for influenza virus A (H5N1)Emerging Infectious Diseases.  15:1250-1259. 2009
2008 TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensisJournal of Leukocyte Biology.  84:1434-1446. 2008
2008 Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune responseImmunological Reviews.  225:68-84. 2008
2008 A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza virusesJournal of Infectious Diseases.  197:1185-1188. 2008
2008 Influenza A virus (H3N8) in dogs with respiratory disease, FloridaEmerging Infectious Diseases.  14:902-908. 2008
2007 Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006Journal of Infectious Diseases.  196:1685-1691. 2007
2007 New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in miceClinical Pharmacology and Therapeutics.  82:665-671. 2007
2007 DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza h5N1 virus infectionJournal of Infectious Diseases.  196:1493-1499. 2007
2007 Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in miceClinical and Diagnostic Laboratory Immunology.  14:926-928. 2007
2007 NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-IAmerican Journal of Respiratory Cell and Molecular Biology.  36:263-269. 2007
2007 No evidence of avian influenza A (H5N1) among returning US travelersEmerging Infectious Diseases.  13:294-297. 2007
2007 Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.Influenza and Other Respiratory Viruses.  1:95-104. 2007
2006 Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004Emerging Infectious Diseases.  12:1841-1847. 2006
2006 Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsClinical Infectious Diseases.  43:1135-1142. 2006
2006 Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVSInfection and Immunity.  74:2809-2816. 2006
2005 A distal regulatory region is required for constitutive and IFN-β-induced expression of murine TLR9 geneJournal of Immunology.  175:7407-7418. 2005
2005 Evolution of H5N1 avian influenza viruses in AsiaEmerging Infectious Diseases.  11:1515-1521. 2005
2005 Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin BInfection and Immunity.  73:3990-3998. 2005
2005 Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: A potential priming strategyJournal of Infectious Diseases.  191:1210-1215. 2005
2005 Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center.Clinical Infectious Diseases.  40. 2005
2004 Preparing for the next influenza pandemicASM News- American Society for Microbiology.  70:412-419. 2004
2004 Innate immunity in aging: Impact on macrophage functionAging Cell.  3:161-167. 2004
2004 Immunity to influenza: The challenges of protecting an aging populationImmunologic Research.  29:113-124. 2004
2004 Antigenic characteristics of recent avian influenza A H5N1 viruses isolated from humansInternational Congress Series.  1263:109-113. 2004
2004 Impaired antigen-induced CD8 + T cell clonal expansion in aging is due to defects in antigen presenting cell functionCellular Immunology.  229:86-92. 2004
2004 Influenza pandemic vaccines: The imminent challenges from a technical and regulatory perspectiveInternational Congress Series.  1263:51-54. 2004
2004 Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccinesInternational Congress Series.  1263:724-727. 2004
2004 Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalisInfection and Immunity.  72:637-644. 2004
2004 Human illness from avian influenza H7N3, British ColumbiaEmerging Infectious Diseases.  10:2196-2199. 2004
2003 Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharideJournal of Immunology.  171:717-725. 2003
2003 Role of innate immune factors in the adjuvant activity of monophosphoryl lipid AInfection and Immunity.  71:2498-2507. 2003
2003 Current methods for assessing T cell responses to influenza.Developments in Biological Standardization.  115:85-93. 2003
2003 Feasibility of an HA2 domain-based periodontitis vaccineInfection and Immunity.  71:562-566. 2003
2003 Systemic and cellular immunity.Developments in Biological Standardization.  115:107-109. 2003
2002 Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infectionInfection and Immunity.  70:6779-6787. 2002
2002 Cutting edge: Impaired toll-like receptor expression and function in agingJournal of Immunology.  169:4697-4701. 2002
2002 Microbial/host interactions: Mechanisms involved in host responses to microbial antigensImmunologic Research.  26:223-234. 2002
2002 Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalisInfection and Immunity.  70:3557-3565. 2002
2002 Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipainsInfection and Immunity.  70:2512-2518. 2002
2002 DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in miceEmerging Infectious Diseases.  8:796-801. 2002
2002 Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999Emerging Infectious Diseases.  8:154-159. 2002
2002 Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998Journal of Infectious Diseases.  185:1005-1010. 2002
2001 Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coliJournal of Immunology.  167:5278-5285. 2001
2001 Molecular correlates of influenza A H5N1 virus pathogenesis in miceInternational Congress Series.  1219:595-600. 2001
2001 Mucosal vaccination protects mice against influenza A heterosubtypic challengeInternational Congress Series.  1219:985-992. 2001
2001 Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage functionCellular Immunology.  211:143-153. 2001
2001 A vaccine against dental caries: An overviewClinical immunotherapeutics.  15:501-508. 2001
2001 Vaccines against avian influenza A H9N2 virusesInternational Congress Series.  1219:783-788. 2001
2000 Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexesInfection and Immunity.  68:1441-1449. 2000
2000 Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong KongJournal of Infectious Diseases.  181:344-348. 2000
2000 Avian influenza viruses infecting humansCellular and Molecular Life Sciences.  57:1770-1784. 2000
2000 Pathogenesis of and immunity to avian influenza A H5 virusesBiomedicine and Pharmacotherapy.  54:178-187. 2000
1999 Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contactsJournal of Infectious Diseases.  180:1763-1770. 1999
1999 Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997Journal of Infectious Diseases.  180:505-508. 1999
1999 Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat modelInfection and Immunity.  67:4352-4359. 1999
1999 Detection of antibody to avian influenza a (H5N1) virus in human serum by using a combination of serologic assaysJournal of Clinical Microbiology.  37:937-943. 1999
1997 Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccineJournal of Infectious Diseases.  175:352-363. 1997
1997 Passive Immunization against Dental Plaque Formation in Humans: Effect of a Mouth Rinse Containing Egg Yolk Antibodies (IgY) Specific to Streptococcus mutansCaries Research.  31:268-274. 1997
1995 Induction of salivary IgA responses to Streptococcus mutans antigen I/II after intranasal immunizationAdvances in Experimental Medicine and Biology.  371:1153-1156. 1995
1995 Oral immunization studies with streptococcus mutans and influenza vaccines in rhesus macaque monkeysAdvances in Experimental Medicine and Biology.  371:1423-1429. 1995
1993 Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxinInfection and Immunity.  61:1964-1971. 1993
1992 Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responsesAdvances in Experimental Medicine and Biology.  327:191-198. 1992
1992 Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cellsJournal of General Virology.  73:1159-1165. 1992
1992 Application of directigen FLU-A for the detection of influenza A virus in human and nonhuman specimensJournal of Clinical Microbiology.  30:1072-1075. 1992
1992 Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cellsJournal of Immunology.  149:1319-1325. 1992
1992 Extent of γδ T cell involvement in the pneumonia caused by sendai virusCellular Immunology.  143:183-193. 1992
1992 Humoral response to Porphyromonas (Bacteroides) gingivalis in rats: Time course and T-cell dependenceInfection and Immunity.  60:3579-3585. 1992
1991 A method for generating antigen-specific rat T helper cell clonesJournal of Immunological Methods.  138:77-86. 1991
1991 Effect of immune bovine milk on Streptococcus mutans in human dental plaqueArchives of Oral Biology.  36:41-47. 1991
1990 Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigenInfection and Immunity.  58:2785-2791. 1990
1989 Efficacy of Inactivated Influenza a Virus (H3N2) Vaccines Grown in Mammalian Cells or Embryonated EggsJournal of Infectious Diseases.  160:191-198. 1989
1989 Liposomes as oral adjuvants.Current Topics in Microbiology and Immunology.  146:51-58. 1989
1987 Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptocococcus mutansInfection and Immunity.  55:2341-2347. 1987
1987 Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutininCellular Immunology.  109:12-24. 1987
1987 Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses.Advances in Experimental Medicine and Biology.  216 B:1741-1747. 1987
1987 Oral vaccines and the secretory immune systemClinical Immunology Newsletter.  8:158-159. 1987
1985 Cleavage of bovine skin type III collagen by proteolytic enzymes. Relative resistance of the fibrillar formJournal of Biological Chemistry.  260:16411-16417. 1985
1985 Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chainsJournal of Immunology.  134:616-622. 1985
1981 In vitro antibody response to influenza virus. II. Specificity of helper T cells recognizing hemagglutininJournal of Immunology.  127:669-672. 1981


Year Title Altmetric
2009 Chapter 2 Use of Animal Models to Understand the Pandemic Potential of Highly Pathogenic Avian Influenza Viruses.  Ed. 73.  2009
2007 WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines 2007
2004 Influenza vaccines generated by reverse genetics.  Ed. 283.  2004


Year Title Altmetric
2012 Inactivated influenza vaccines.  257-293. 2012

Education And Training

  • Doctor of Philosophy in Immunopathology Residency Program, University of Alabama at Birmingham 1992
  • Doctor of Dental Science in Dentistry, National Autonomous University of Mexico 1980
  • Full Name

  • Jannet Katz